Scott J Johnson (Scott Johnson)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Acute Lymphoblastic Leukemia

Juvenile Idiopathic Arthritis

Affordable Care Act

Top Venues

Advances in therapy

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Alice Kate Cummings Joyner, Julia Thornton Snider, Sally West Wade, Si-Tien Wang, Marric G Buessing, Scott J Johnson, Usama Gergis
Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care. Advances in therapy 39 (8) (2022)
Bridget M Hron, Russell D Cohen, Scott J Johnson, Martha Skup, Jingdong Chao, Stacy A Kahn
Letter: is unrealised adult height resulting from paediatric Crohn's disease associated with a potential reduction in lifetime earnings? Alimentary pharmacology & therapeutics 52 (3) (2020)
Remo Panaccione, Jean-Frederic Colombel, Simon P L Travis, Peter Bossuyt, Filip Baert, Tomáš Vaňásek, Ahmet Danalıoğlu, Gottfried Novacek, Alessandro Armuzzi, Walter Reinisch, Scott J Johnson, Marric Buessing, Ezequiel Neimark, Joel Petersson, Wan-Ju Lee, Geert R D'Haens
Tight control for Crohn's disease with adalimumab-based treatment is cost-effective: an economic assessment of the CALM trial. Gut 69 (4) (2019)